S. Korean biosimilar Herzuma on sale in Britain

S. Korean biosimilar Herzuma on sale in Britain

3Herzuma, an anti-cancer biosimilar produced by South Korea's biopharmaceutical group Celltrion, has been put on sale in Britain following approval from Europe's regulatory body.

Celltrion Healthcare, the distribution wing of Celltrion, said that Herzuma, used to treat breast cancer, was officially launched in Britain. Herzuma based on Herceptin developed by Genentech, a subsidiary of Swiss pharmaceutical giant Roche was approved by the European Medicines Agency in February.

 

See URL for details : http://www.ajudaily.com/view/20180503171239029

Source : AJUDAILY

Print Friendly, PDF & Email

Heewon Shim

Leave a Reply

Close